Kemp B - Search Results

1

Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer.

Wu X, Kemp B, Amos CI, Honn SE, Zhang W, Walsh GL, Spitz MR. Wu X, et al. Among authors: kemp b. Br J Cancer. 1999 May;80(3-4):453-7. doi: 10.1038/sj.bjc.6690378. Br J Cancer. 1999. PMID: 10408853 Free PMC article.

2

Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer.

Wu X, Shi H, Jiang H, Kemp B, Hong WK, Delclos GL, Spitz MR. Wu X, et al. Among authors: kemp b. Carcinogenesis. 1997 May;18(5):967-73. doi: 10.1093/carcin/18.5.967. Carcinogenesis. 1997. PMID: 9163682

3

Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.

Swisher SG, Roth JA, Komaki R, Gu J, Lee JJ, Hicks M, Ro JY, Hong WK, Merritt JA, Ahrar K, Atkinson NE, Correa AM, Dolormente M, Dreiling L, El-Naggar AK, Fossella F, Francisco R, Glisson B, Grammer S, Herbst R, Huaringa A, Kemp B, Khuri FR, Kurie JM, Liao Z, McDonnell TJ, Morice R, Morello F, Munden R, Papadimitrakopoulou V, Pisters KM, Putnam JB Jr, Sarabia AJ, Shelton T, Stevens C, Shin DM, Smythe WR, Vaporciyan AA, Walsh GL, Yin M. Swisher SG, et al. Among authors: kemp b. Clin Cancer Res. 2003 Jan;9(1):93-101. Clin Cancer Res. 2003. PMID: 12538456 Clinical Trial.

4

Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors.

Ford MB, Sigurdson AJ, Petrulis ES, Ng CS, Kemp B, Cooksley C, McNeese M, Selwyn BJ, Spitz MR, Bondy ML. Ford MB, et al. Among authors: kemp b. Cancer. 2003 Oct 1;98(7):1457-64. doi: 10.1002/cncr.11669. Cancer. 2003. PMID: 14508833 Free article.

5

hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer.

Wang L, Soria JC, Kemp BL, Liu DD, Mao L, Khuri FR. Wang L, et al. Clin Cancer Res. 2002 Sep;8(9):2883-9. Clin Cancer Res. 2002. PMID: 12231532

6

Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.

Hastürk S, Kemp B, Kalapurakal SK, Kurie JM, Hong WK, Lee JS. Hastürk S, et al. Among authors: kemp b. Cancer. 2002 Feb 15;94(4):1023-31. Cancer. 2002. PMID: 11920472 Free article.

7

Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.

Soria JC, Lee HY, Lee JI, Wang L, Issa JP, Kemp BL, Liu DD, Kurie JM, Mao L, Khuri FR. Soria JC, et al. Clin Cancer Res. 2002 May;8(5):1178-84. Clin Cancer Res. 2002. PMID: 12006535

8

Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer.

Soria JC, Moon C, Kemp BL, Liu DD, Feng L, Tang X, Chang YS, Mao L, Khuri FR. Soria JC, et al. Clin Cancer Res. 2003 May;9(5):1785-91. Clin Cancer Res. 2003. PMID: 12738735

9

Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.

Herbst RS, Yano S, Kuniyasu H, Khuri FR, Bucana CD, Guo F, Liu D, Kemp B, Lee JJ, Hong WK, Fidler IJ. Herbst RS, et al. Among authors: kemp b. Clin Cancer Res. 2000 Mar;6(3):790-7. Clin Cancer Res. 2000. PMID: 10741698

10

Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.

Lu C, Soria JC, Tang X, Xu XC, Wang L, Mao L, Lotan R, Kemp B, Bekele BN, Feng L, Hong WK, Khuri FR. Lu C, et al. Among authors: kemp b. J Clin Oncol. 2004 Nov 15;22(22):4575-83. doi: 10.1200/JCO.2004.01.091. J Clin Oncol. 2004. PMID: 15542809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,291 results

Search Page

Filters